Marylyn Addo
#57,682
Most Influential Person Now
German infectiologist
Marylyn Addo's AcademicInfluence.com Rankings
Marylyn Addophilosophy Degrees
Philosophy
#11118
World Rank
#15261
Historical Rank
Logic
#7910
World Rank
#9841
Historical Rank
Download Badge
Philosophy
Marylyn Addo's Degrees
- Doctorate Medicine University of Hamburg
- PhD Infectious Diseases University of Hamburg
Why Is Marylyn Addo Influential?
(Suggest an Edit or Addition)According to Wikipedia, Marylyn Martina Addo is a German infectiologist who is a Professor and the German Center for Infection Research Head of Infectious Disease at the University Medical Center Hamburg-Eppendorf. Addo has developed and tested vaccinations that protect people from Ebola virus disease and the MERS coronavirus EMC/2012. She is currently developing a viral vector based COVID-19 vaccine.
Marylyn Addo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 (2020) (1550)
- The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation (2010) (1129)
- HIV evolution: CTL escape mutation and reversion after transmission (2004) (921)
- Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA (2004) (858)
- Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load (2003) (756)
- Evolution and transmission of stable CTL escape mutations in HIV infection (2001) (602)
- Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. (2008) (554)
- Adaptation of HIV-1 to human leukocyte antigen class I (2009) (475)
- Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection (2001) (429)
- Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection (2003) (392)
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. (2016) (389)
- Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T Cells (2004) (383)
- Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein1 (2005) (376)
- Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. (2005) (339)
- Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection (2004) (330)
- Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities (2004) (310)
- Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection (2001) (298)
- A case of severe Ebola virus infection complicated by gram-negative septicemia. (2014) (275)
- Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation (2002) (271)
- Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes (2006) (256)
- Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells (2009) (223)
- Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease (2020) (222)
- The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. (2001) (219)
- Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion (2012) (213)
- Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides (2004) (199)
- Elite control of HIV infection: implications for vaccines (2006) (194)
- Limited Durability of Viral Control following Treated Acute HIV Infection (2004) (189)
- Frequent neurocognitive deficits after recovery from mild COVID-19 (2020) (179)
- Control of Human Immunodeficiency Virus Type 1 Is Associated with HLA-B*13 and Targeting of Multiple Gag-Specific CD8+ T-Cell Epitopes (2007) (165)
- Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection (2004) (159)
- Consistent Patterns in the Development and Immunodominance of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T-Cell Responses following Acute HIV-1 Infection (2002) (151)
- Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. (2003) (147)
- Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences (2003) (147)
- Unique human immune signature of Ebola virus disease in Guinea (2016) (143)
- Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes (2008) (140)
- HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication (2004) (130)
- HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity (2004) (128)
- The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. (2005) (123)
- Sex-based differences in HIV type 1 pathogenesis. (2014) (123)
- Scent dog identification of samples from COVID-19 patients – a pilot study (2020) (122)
- HIV-1–specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor–α (2004) (122)
- Fully Differentiated HIV-1 Specific CD8+ T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection (2007) (122)
- Vpr Is Preferentially Targeted by CTL During HIV-1 Infection1 (2001) (116)
- Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot Assay (2000) (110)
- Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif (2001) (107)
- Beyond Help: Direct Effector Functions of Human Immunodeficiency Virus Type 1-Specific CD4+ T Cells (2004) (105)
- Ebola and Psychological Stress of Health Care Professionals (2015) (100)
- Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users (1995) (99)
- Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV (2017) (95)
- Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV (2017) (95)
- IL-8 responsiveness defines a subset of CD8 T cells poised to kill. (2004) (93)
- HIV-1 Antiviral Activity of Recombinant Natural Killer Cell Enhancing Factors, NKEF-A and NKEF-B, Members of the Peroxiredoxin Family* (2003) (93)
- Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial (2020) (90)
- Bat3 Protects T cell Responses by Repressing Tim-3-Mediated Exhaustion and Death (2012) (87)
- SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients (2021) (85)
- Clonal expansion and activation of tissue-resident memory-like TH17 cells expressing GM-CSF in the lungs of patients with severe COVID-19 (2021) (81)
- HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. (2004) (77)
- HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients. (2018) (74)
- Preserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue. (2012) (68)
- Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV (2019) (67)
- Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. (2006) (66)
- Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization (2003) (65)
- Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. (2005) (64)
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization☆ (2017) (63)
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization☆ (2017) (63)
- Molecular consequences of SARS-CoV-2 liver tropism (2022) (61)
- Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection. (2002) (60)
- HIV-specific CD8 T cells express low levels of IL-7Ralpha: implications for HIV-specific T cell memory. (2006) (59)
- GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. (2006) (58)
- Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection (2013) (55)
- Rev activity determines sensitivity of HIV-1-infected primary T cells to CTL killing. (2003) (52)
- Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients (2020) (51)
- The Majority of Currently Circulating Human Immunodeficiency Virus Type 1 Clade B Viruses Fail To Prime Cytotoxic T-Lymphocyte Responses against an Otherwise Immunodominant HLA-A2-Restricted Epitope: Implications for Vaccine Design (2005) (46)
- Acute Ebola virus disease patient treatment and health-related quality of life in health care professionals: A controlled study. (2016) (45)
- Correlates of Vaccine-Induced Protection against SARS-CoV-2 (2021) (44)
- Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens (2019) (44)
- Ex Vivo Cytosolic Delivery of Functional Macromolecules to Immune Cells (2015) (42)
- Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022 (2022) (40)
- TH1 to TH2 Shift of Cytokines in Peripheral Blood of HIV‐Infected Patients Is Detectable by Reverse Transcriptase Polymerase Chain Reaction but Not by Enzyme‐Linked Immunosorbent Assay Under Nonstimulated Conditions (2000) (40)
- Comprehensive Characterization of Cellular Immune Responses Following Ebola Virus Infection. (2016) (38)
- CD4+ CD25+ Regulatory T Cells Impair HIV-1-Specific CD4 T Cell Responses by Upregulating Interleukin-10 Production in Monocytes (2012) (36)
- B cell analysis in SARS‐CoV‐2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID‐19 (2020) (35)
- Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19 (2020) (35)
- Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses (2002) (34)
- SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies (2021) (33)
- Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza (2021) (33)
- Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series (2020) (32)
- Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients (2015) (31)
- Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study (2020) (31)
- TH1 to TH2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions. (2000) (30)
- Consensus statement on antiretroviral treatment for AIDS in poor countries. (2001) (30)
- HIV-specific CD 8 T cells express low levels of IL-7 R alpha : Implications for HIV-specific T cell memory (30)
- Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens (2021) (30)
- Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria (2018) (26)
- HIV-1 Vpu represents a minor target for cytotoxic T lymphocytes in HIV-1-infection. (2002) (26)
- Sharp increase of imported Plasmodium vivax malaria seen in migrants from Eritrea in Hamburg, Germany (2016) (24)
- Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans (2018) (24)
- CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects (2004) (24)
- Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans (2018) (24)
- HIV-1 infection impairs regulatory T-cell suppressive capacity on a per-cell basis. (2014) (23)
- Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus. (2022) (22)
- Tropheryma whipplei in children with diarrhoea in rural Ghana. (2016) (21)
- Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study (2017) (21)
- Regulatory and accessory HIV-1 proteins: potential targets for HIV-1 vaccines? (2005) (20)
- Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) (2020) (20)
- SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia (2021) (19)
- Lack of Detectable HIV-1–Specific CD8+ T Cell Responses in Zambian HIV-1–Exposed Seronegative Partners of HIV-1–Positive Individuals (2011) (18)
- Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020 (2021) (18)
- Pre-travel advice at a crossroad: Medical preparedness of travellers to South and Southeast-Asia - The Hamburg Airport Survey. (2017) (18)
- Severe Ebola virus infection complicated by gram-negative septicemia. (2015) (18)
- Helminthic infections in returning travelers and migrants with eosinophilia: Diagnostic value of medical history, eosinophil count and IgE. (2017) (18)
- Scent dog identification of SARS-CoV-2 infections in different body fluids (2021) (17)
- Differences in the expressed HLA class I alleles effect the differential clustering of HIV type 1-specific T cell responses in infected Chinese and caucasians. (2004) (16)
- Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection (2013) (15)
- Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study) (2019) (14)
- Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients (2022) (14)
- Cellular immune responses in transplantation‐associated chronic viral infections (2002) (13)
- Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic (2021) (13)
- Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series (2021) (13)
- Human Immunodeficiency Virus Type 1-Specific CD 8 T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD 4 T Cells † (2009) (13)
- Cellular immune responses in transplantation‐associated chronic viral infections (2002) (13)
- Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection (2022) (12)
- Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients (2022) (12)
- A Case of Iced-Tea Nephropathy (2015) (12)
- Comparison of autochthonous and imported cases of hepatitis A or hepatitis E (2015) (12)
- Hepatitis E virus persists in the ejaculate of chronically infected men. (2021) (11)
- No link between male infertility and HEV genotype 3 infection (2019) (11)
- SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease (2022) (11)
- Discrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs (2021) (11)
- Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins (2020) (10)
- Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta‐analysis (2020) (10)
- Rapid-Antigen Test Negative Malaria in a Traveler Returning From Thailand, Molecularly Diagnosed as Plasmodium knowlesi (2016) (10)
- Rapid Adaptation of Established High-Throughput Molecular Testing Infrastructure for Monkeypox Virus Detection (2022) (10)
- Regulatory T Cells Expanded from HIV-1-Infected Individuals Maintain Phenotype, TCR Repertoire and Suppressive Capacity (2014) (9)
- Transmission of oral Candida albicans strains between HIV-positive patients (1995) (9)
- Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients (2021) (9)
- Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study (2020) (9)
- Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19 (2021) (8)
- Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (8)
- Determinants of post-malarial anemia in African children treated with parenteral artesunate (2019) (8)
- Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern—A first case‐series experience (2022) (8)
- Respiratory muscle dysfunction in long-COVID patients (2022) (7)
- Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center (2018) (7)
- Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues (2021) (7)
- Clinical Presentation and Disease Course of 37 Consecutive Cases of Progressive Multifocal Leukoencephalopathy (PML) at a German Tertiary-Care Hospital: A Retrospective Observational Study (2021) (7)
- Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (7)
- Epitopes of Naturally Acquired and Vaccine‐Induced Anti‐Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution (2020) (7)
- T cells expressing multiple co-inhibitory molecules in acute malaria are not exhausted but exert a suppressive function (2021) (6)
- Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial (2022) (6)
- Molecular Diagnosis of Human Taenia martis Eye Infection. (2016) (6)
- Brain magnetic resonance imaging in imported malaria (2019) (6)
- Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness (2021) (6)
- Transjugular Intrahepatic Portosystemic Shunt (TIPS) for primary and secondary prophylaxis of variceal bleeding in hepatic schistosomiasis. (2019) (6)
- [Sex differences in infectious diseases and their clinical consequences]. (2015) (5)
- SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia (2022) (5)
- Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine (2022) (5)
- High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4+ T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19 (2022) (5)
- [Medical care for asylum seekers and refugees at the University Medical Center Hamburg-Eppendorf--A case series]. (2016) (5)
- Regulatory T cell frequencies do not correlate with breadth or magnitude of HIV-1-specific T cell responses. (2012) (5)
- Risk factors for and management of metronidazole-refractory giardiasis in international travellers: a retrospective analysis. (2021) (5)
- [Management of seasonal influenza in 2017/2018 at a German tertiary-care hospital]. (2019) (4)
- Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity. A randomized clinical trial (2022) (4)
- New tools to expand regulatory T cells from HIV-1-infected individuals. (2013) (4)
- The COVID-19 Vaccine Landscape. (2021) (4)
- Integration of microarray data and literature mining identifies a sex bias in DPP4+CD4+ T cells in HIV-1 infection (2020) (4)
- A simple, sensitive, and low‐cost FACS assay for detecting antibodies against the native SARS‐CoV‐2 spike protein (2021) (4)
- Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV. (2018) (4)
- Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic (2022) (4)
- Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome (2022) (4)
- Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection (2020) (4)
- Acute HIV-1 infection is associated with increased plasma levels of heme oxygenase-1 and presence of heme oxygenase-1-specific regulatory T cells (2017) (4)
- Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers (2022) (3)
- Update on the “Choosing Wisely” initiative in infectious diseases in Germany (2020) (3)
- Risk factors for different intestinal pathogens among patients with traveler's diarrhea: A retrospective analysis at a German travel clinic (2009-2017). (2020) (3)
- High‐resolution analysis of individual spike peptide‐specific CD4 + T‐cell responses in vaccine recipients and COVID‐19 patients (2022) (3)
- Relapsing cutaneous leishmaniasis in a patient requiring TNF-α-inhibitor Infliximab for Takayasu-arteritis: Case report and review of the literature. (2020) (3)
- High effectiveness of multimodal infection control interventions in preventing SARS-CoV-2 infections in healthcare professionals: a prospective longitudinal seroconversion study (2020) (3)
- Scent dog identification of SARS-CoV-2 infections, similar across different body fluids (2021) (3)
- CD 8 + T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects (2004) (2)
- Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study (2022) (2)
- A Dead-End Host: Is There a Way Out? A Position Piece on the Ebola Virus Outbreak by the International Union of Immunology Societies (2014) (2)
- Author Correction: Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria (2018) (2)
- Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants (2022) (2)
- The Effects of SARS-CoV-2 Virus Type and of Vaccination Status on Causes of Death Over the Course of the COVID-19 Pandemic. (2022) (2)
- Predictors of somatic symptom burden in healthcare professionals during the COVID-19 pandemic: an 8-week follow-up study. (2022) (2)
- Seroconversion of HBsAG coincides super-infection with hepatitis A: A case report (2020) (2)
- Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19 (2021) (2)
- Usp18 Expression in CD169+ Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV (2020) (2)
- Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial (2021) (1)
- Debunking Misinformation and Communicating Critical Events in Vaccine Trials (2022) (1)
- Extensive Antibiotic and Antimalarial Prescription Rate among Children with Acute Febrile Diseases in the Lake Victoria Region, Tanzania. (2021) (1)
- Respiratory Muscle Dysfunction in COVID-19 Patients with Persistent Symptoms (2021) (1)
- Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (1)
- Multiplex-RT-PCR-ELISA panel for detecting mosquito-borne pathogens: Plasmodium sp. preserved and eluted from dried blood spots on sample cards (2021) (1)
- Brief Report: Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Subjects Vaccinated with Modified Vaccinia Virus Ankara Encoding MERS-Coronavirus Spike Protein. (2023) (1)
- Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection (2013) (1)
- Seroconversion of HBsAG coincides with hepatitis A super-infection: A case report. (2020) (1)
- Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity (2022) (1)
- A call to caution when hydroxychloroquine is given to elderly patients with COVID-19 (2021) (1)
- TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis–A case series and review of the literature (2021) (1)
- Integrin Alpha E (CD103) Limits Virus-Induced IFN-I Production in Conventional Dendritic Cells (2021) (1)
- Impact of antibiotic intake on incidence of extended spectrum beta-lactamase producing Enterobacterales in sub-Saharan Africa - results from a community-based longitudinal study. (2022) (1)
- Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection (2013) (1)
- Emerging Infections (2015) (1)
- Less than you'd think-a prospective study on MRSA-colonization in healthy travelers. (2021) (1)
- HIV Long-Term Nonprogression : Insights Into Pathogenesis and Viral Control (2003) (1)
- Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study (2017) (0)
- During HIV-1 Infection Vpr Is Preferentially Targeted by CTL Rosenberg and (2001) (0)
- [Correction: The COVID-19 pandemic - an epochal event]. (2022) (0)
- Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis (2023) (0)
- Mini-laparoscopy as a diagnostic tool for abdominal tuberculosis: a retrospective series of 29 cases (2022) (0)
- Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens (2022) (0)
- Author Correction: Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria (2018) (0)
- [Recurrent vomiting and headaches in a 26-year-old male patient]. (2019) (0)
- SAT-167-Hepatitis-E-genome sequencing via capture-probe targeting and NGS allows characterisation of viral variability (2019) (0)
- Sex differences in the percentage of IRF5 positive B cells are associated with higher production of TNF-α in women in response to TLR9 in humans (2023) (0)
- Fluctuations of functionally distinct CD8 (cid:1) T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire (2006) (0)
- Resource Systems Vaccinology Iden tifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV Graphical (2017) (0)
- Hepatitis E virus shedding in semen of chronically, but not acute HEV infected individuals (2020) (0)
- 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial (2022) (0)
- Regulatory T cells can be expanded from HIV-1 infected individuals with preservation of suppressive function and TCR repertoire (2012) (0)
- Impact of heme oxygenase-1 specific CD8+ regulatory T cells on HIV-1 immunity (2011) (0)
- Long-Term Antibody Response to SARS-CoV-2 in Children (2022) (0)
- Multiplex-RT-PCR-ELISA panel for detecting mosquito-borne pathogens: Plasmodium sp. preserved and eluted from dried blood spots on sample cards (2021) (0)
- β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training (2023) (0)
- [A survey on the vaccination status of COVID-19 patients in intensive care units in Hamburg]. (2022) (0)
- Attitudes, practices, and obstacles towards influenza vaccination for international travelers among travel health advisors in Germany: A questionnaire-based survey (2021) (0)
- [The COVID-19 pandemic - an epochal event]. (2022) (0)
- Validation of a Prospective Urinalysis-Based Prediction Model for the Outcome of COVID-19 Disease: A Multicenter Cohort Study (2020) (0)
- Brain magnetic resonance imaging in imported malaria (2019) (0)
- Risk factors for a suboptimal immune response to SARS-CoV-2 vaccination in liver transplant recipients (2022) (0)
- Regulatory T Cells Impair HIV-1-Specific CD 4 T Cell Responses by Upregulating Interleukin-10 Production in Monocytes (2012) (0)
- Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection (2022) (0)
- Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections (2023) (0)
- Blood donors in Europe have substantially higher risk of exposure to HEV than in North America: results from a systematic review and meta-analysis (2022) (0)
- Sharp increase of imported Plasmodium vivax malaria seen in migrants from Eritrea in Hamburg, Germany (2016) (0)
- Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022 (2022) (0)
- Regulatory T cells can be expanded from HIV-1 infected individuals with preservation of suppressive function and TCR repertoire (170.26) (2012) (0)
- Protein Primarily against the Adenovirus Hexon Serotype 5 Vaccine Vectors Are Directed Neutralizing Antibodies to Adenovirus (2005) (0)
- Primary HIV-1 infection is associated with increased plasma levels of heme-oxygenase-1 (HO-1) and presence of HO-1-specific regulatory T cells. (2012) (0)
- Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General (2021) (0)
- flexibility of the HIV-specific TCR repertoire T-cell clonotypes demonstrate + Fluctuations of functionally distinct CD 8 (2006) (0)
- Tuberculous Tenosynovitis. (2018) (0)
- ’ s response to reviews Title : Scent dog identification of samples from COVID-19 patients – a pilot study (2020) (0)
- [Less is more… in infectious diseases]. (2021) (0)
- Hepatitis E seroprevalence and rate of viremia in immunocompromised patients - a systematic review and meta-analysis (2020) (0)
- Seroprevalence of specific antibodies during pregnancy and risk for early life infectious diseases (2020) (0)
- Symptoms of illness during travel and risk factors for non-adherence to malaria prophylaxis-a cross-sectional study in travellers from Germany. (2023) (0)
- Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses (2023) (0)
- Antibiotic and Anti-Malarial Prescription Rate among Children with Acute Febrile Diseases in the Lake Victoria Region, Mwanza, Tanzania (2019) (0)
- [Travel medicine picks up speed again!] (2022) (0)
- Human Immunodeficiency Virus Type 1-Specific CD8 (cid:1) T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4 (cid:1) T Cells (cid:1) † (2009) (0)
- Beyond Help: Direct Effector Functions of Human Immunodeficiency Virus Type 1-Specific CD4 (cid:1) T Cells (2004) (0)
- Living Repository of Millions of T and B Cell Receptor Sequences from Patients with COVID-19 (2020) (0)
- Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease (2023) (0)
- Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria (2018) (0)
- Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave (2023) (0)
This paper list is powered by the following services:
Other Resources About Marylyn Addo
What Schools Are Affiliated With Marylyn Addo?
Marylyn Addo is affiliated with the following schools:
